Header Logo

Connection

CHARLES WYKOFF to Genetic Therapy

Back to Details
This is a "connection" page, showing publications CHARLES WYKOFF has written about Genetic Therapy.
CHARLES WYKOFF
Connection Strength
0.040
Genetic Therapy
  1. Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study. Lancet. 2024 04 20; 403(10436):1563-1573.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.